299 related articles for article (PubMed ID: 12590709)
1. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
[TBL] [Abstract][Full Text] [Related]
2. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
3. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis.
Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO
Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045
[TBL] [Abstract][Full Text] [Related]
5. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint.
Biondi A; Luciano A; Bassan R; Mininni D; Specchia G; Lanzi E; Castagna S; Cantù-Rajnoldi A; Liso V; Masera G
Leukemia; 1995 Sep; 9(9):1461-6. PubMed ID: 7658712
[TBL] [Abstract][Full Text] [Related]
6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
[TBL] [Abstract][Full Text] [Related]
7. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform.
Foley R; Soamboonsrup P; Carter RF; Benger A; Meyer R; Walker I; Wan Y; Patterson W; Orzel A; Sunisloe L; Leber B; Neame PB
Am J Hematol; 2001 May; 67(1):34-41. PubMed ID: 11279655
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases.
Guglielmi C; Martelli MP; Diverio D; Fenu S; Vegna ML; Cantù-Rajnoldi A; Biondi A; Cocito MG; Del Vecchio L; Tabilio A; Avvisati G; Basso G; Lo Coco F
Br J Haematol; 1998 Sep; 102(4):1035-41. PubMed ID: 9734655
[TBL] [Abstract][Full Text] [Related]
10. Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
Schoch C; Schnittger S; Kern W; Lengfelder E; Löffler H; Hiddemann W; Haferlach T
Hematol J; 2002; 3(5):259-63. PubMed ID: 12391544
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
Benedetti L; Levin AA; Scicchitano BM; Grignani F; Allenby G; Diverio D; Lo Coco F; Avvisati G; Ruthardt M; Adamo S; Pelicci PG; Nervi C
Blood; 1997 Aug; 90(3):1175-85. PubMed ID: 9242550
[TBL] [Abstract][Full Text] [Related]
12. PML/RAR alpha(+) hypergranular acute promyelocytic leukemia (M3) developing into an M3 acute myelocytic leukemia without PML/RAR alpha.
Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Reyes-Núñez V
Acta Haematol; 2000; 104(2-3):124-7. PubMed ID: 11154988
[TBL] [Abstract][Full Text] [Related]
13. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
Martinelli G; Ottaviani E; Visani G; Testoni N; Montefusco V; Tura S
Haematologica; 1998 Sep; 83(9):860-3. PubMed ID: 9825588
[TBL] [Abstract][Full Text] [Related]
14. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
Falini B; Flenghi L; Fagioli M; Lo Coco F; Cordone I; Diverio D; Pasqualucci L; Biondi A; Riganelli D; Orleth A; Liso A; Martelli MF; Pelicci PG; Pileri S
Blood; 1997 Nov; 90(10):4046-53. PubMed ID: 9354674
[TBL] [Abstract][Full Text] [Related]
16. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF
Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RARalpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3.
Virchis A; Massey E; Butler T; Devaraj P; Wright F; Secker-Walker L; Prentice HG; Mehta A
Br J Haematol; 2001 Sep; 114(3):551-6. PubMed ID: 11552979
[TBL] [Abstract][Full Text] [Related]
18. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia.
Jiang XW; Chen SZ; Zhu XY; Xu XX; Liu Y
Mol Cell Probes; 2020 Oct; 53():101617. PubMed ID: 32585184
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCR.
Chen H; Pan J; Yao L; Wu L; Zhu J; Wang W; Liu C; Han Q; Du G; Cen J; Xue Y; Wu D; Sun M; Chen S
Cancer Genet; 2012 Jun; 205(6):327-31. PubMed ID: 22749039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
